ArticlePsychiatry research2012

Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: testing the evidence for an endophenotypic marker.

Warrick J Brewer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.